Post by OneAIM

✨ 𝐀𝐈𝐌 𝐈𝐧𝐧𝐨𝐯𝐚𝐭𝐞 𝐖𝐢𝐧𝐭𝐞𝐫 𝐒𝐞𝐦𝐞𝐬𝐭𝐞𝐫 ’25 𝐑𝐞𝐜𝐚𝐩 ✨ Let’s step back to our 𝐀𝐈𝐌 𝐈𝐧𝐧𝐨𝐯𝐚𝐭𝐞 𝐁𝐚𝐭𝐜𝐡 and revisit the journey we’ve taken across the innovation landscape — from first ideas to real clinical impact. From October to December 2025, our participants explored how innovation in healthcare is built end-to-end: from legal foundations and regulatory pathways to venture capital, product development, and digital therapies. ⚖️ 𝐏𝐚𝐭𝐞𝐧𝐭 𝐋𝐚𝐰 & 𝐈𝐏 We started by diving into the foundations of innovation protection. At BARDEHLE PAGENBERG, we gained insights into how patent law firms support innovators in securing and defending their ideas. At the Deutsches Patent- und Markenamt (DPMA), we explored how patent systems work in practice. 🧪 𝐂𝐥𝐢𝐧𝐢𝐜𝐚𝐥 𝐓𝐫𝐢𝐚𝐥𝐬 & 𝐑𝐞𝐠𝐮𝐥𝐚𝐭𝐨𝐫𝐲 At Brainlab, we learned how clinical trials translate innovation into real-world impact At TÜV SÜD, we explored regulatory frameworks and certification processes — and what it takes to bring a medical product to market. 🚀 𝐒𝐭𝐚𝐫𝐭𝐮𝐩𝐬, 𝐕𝐂 & 𝐈𝐝𝐞𝐚𝐭𝐢𝐨𝐧 From idea to scaling — we explored the entrepreneurial side of healthcare. With Redstone, we discussed how venture capital evaluates and scales startups. At Ebenbuild, we gained insights into how innovation is built from concept to product. 🏥 𝐂𝐥𝐢𝐧𝐢𝐜𝐚𝐥 𝐈𝐦𝐩𝐚𝐜𝐭 & 𝐃𝐢𝐠𝐢𝐭𝐚𝐥 𝐓𝐡𝐞𝐫𝐚𝐩𝐞𝐮𝐭𝐢𝐜𝐬 Finally, we looked at how innovation translates into real patient outcomes. At Smith+Nephew, we explored how medical technology drives clinical impact, particularly in orthopaedics and sports medicine. At Cogthera, we discussed how digital solutions are shaping the future of therapy. ✨ 𝐀 𝐡𝐮𝐠𝐞 𝐭𝐡𝐚𝐧𝐤 𝐲𝐨𝐮 𝐭𝐨 𝐚𝐥𝐥 𝐩𝐚𝐫𝐭𝐧𝐞𝐫𝐬 𝐚𝐧𝐝 𝐬𝐩𝐞𝐚𝐤𝐞𝐫𝐬 𝐟𝐨𝐫 𝐭𝐡𝐞𝐢𝐫 𝐢𝐧𝐬𝐢𝐠𝐡𝐭𝐬.